Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 41.99B |
| Enterprise value | 43.71B |
| Trailing P/E | 14.90 |
| Forward P/E | 18.55 |
| PEG ratio (5-yr expected) | 32.54 |
| Price/sales (ttm) | 4.12 |
| Price/book (mrq) | 3.29 |
| Enterprise value/revenue | 4.22 |
| Enterprise value/EBITDA | 10.45 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.21 |
| 52-week change 3 | 29.63% |
| S&P500 52-week change 3 | -9.08% |
| 52-week high 3 | 311.88 |
| 52-week low 3 | 187.16 |
| 50-day moving average 3 | 286.90 |
| 200-day moving average 3 | 240.65 |
Share statistics
| Avg vol (3-month) 3 | 1.2M |
| Avg vol (10-day) 3 | 785.12k |
| Shares outstanding 5 | 144M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 143.57M |
| % held by insiders 1 | 0.68% |
| % held by institutions 1 | 89.89% |
| Shares short (12 Jan 2023) 4 | 1.89M |
| Short ratio (12 Jan 2023) 4 | 1.58 |
| Short % of float (12 Jan 2023) 4 | 1.48% |
| Short % of shares outstanding (12 Jan 2023) 4 | 1.31% |
| Shares short (prior month 14 Dec 2022) 4 | 2.1M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 17 Jan 2001 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 27.64% |
| Operating margin (ttm) | 28.54% |
Management effectiveness
| Return on assets (ttm) | 7.60% |
| Return on equity (ttm) | 20.23% |
Income statement
| Revenue (ttm) | 10.36B |
| Revenue per share (ttm) | 70.97 |
| Quarterly revenue growth (yoy) | -9.70% |
| Gross profit (ttm) | 8.87B |
| EBITDA | 3.49B |
| Net income avi to common (ttm) | 2.86B |
| Diluted EPS (ttm) | 19.62 |
| Quarterly earnings growth (yoy) | 244.70% |
Balance sheet
| Total cash (mrq) | 4.91B |
| Total cash per share (mrq) | 34.1 |
| Total debt (mrq) | 6.63B |
| Total debt/equity (mrq) | 51.96 |
| Current ratio (mrq) | 2.49 |
| Book value per share (mrq) | 88.72 |
Cash flow statement
| Operating cash flow (ttm) | 2.4B |
| Levered free cash flow (ttm) | 2.31B |
© 2023 Yahoo. All rights reserved.
